Cargando…
Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is among the most destructive of tumors, leading to considerable morbidity and mortality. Abnormal immune microenvironment is closely associated with tumor progression. This study aimed to construct a robust immune prognostic model for HNSCC. The RNA-seq...
Autores principales: | Qiu, Yu, Cui, Li, Lin, Yang, Gao, Bingju, Li, Jun, Zhao, Xinyuan, Zhu, Xiaofeng, Hu, Shen, Lin, Lisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667274/ https://www.ncbi.nlm.nih.gov/pubmed/33224866 http://dx.doi.org/10.3389/fonc.2020.01502 |
Ejemplares similares
-
A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Mai, Zizhao, et al.
Publicado: (2022) -
Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021) -
Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020) -
Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021) -
The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma
por: Ming, Ruijie, et al.
Publicado: (2021)